---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-092672"
form_type: "8-K"
ticker: "KTTA"
cik: "0001841330"
company_name: "Pasithea Therapeutics Corp."
filed_at: "2026-08-21T21:05:14+00:00"
generated_at: "2026-08-21T21:06:39.523888+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Pasithea gets Nasdaq 180-day extension to Feb 16, 2027 for bid-price rule

## Summary
- Nasdaq notified Feb 20, 2026 of non-compliance with $1.00 minimum bid price rule 5550(a)(2).
- On Aug 20, 2026, Nasdaq granted 180-day extension to Feb 16, 2027 to regain compliance.
- Company may implement reverse stock split to cure; delisting and appeal rights if not cured.
- No assurance compliance will be achieved within the extension period.

## SEC filing metadata
- accession: 0001213900-26-092672
- form_type: 8-K
- ticker: KTTA
- cik: 0001841330
- company_name: Pasithea Therapeutics Corp.
- filed_at: 2026-08-21T21:05:14+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841330/000121390026092672/0001213900-26-092672-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841330/000121390026092672/ea0302993-8k_pasithea.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-092672
- JSON: https://secwatch.observer/filing/0001213900-26-092672.json
- Plain text: https://secwatch.observer/filing/0001213900-26-092672.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.